Clinical Trial On Brain Death Approved; Can This Really Bring The Dead Back To Life?
A biotech company, which intends to conduct a clinical trial on the dead, has just been granted approval by the U.S. government to proceed with their study on brain death. If successful, the research could result in bringing the dead "back to life." However, it's not quite as scary as it seems as no zombie-like creatures are going to return from the grave.
The trial, which will be facilitated by Bioquark Inc. with Revita Life Sciences and the Anapum Hospital in India, will look into the brains of 20 clinically dead patients who have succumbed because of traumatic brain injuries. The researchers will study the dead's central nervous system using various therapies and stimulation techniques that have already been proven to awaken patients from a coma.
The researchers will also inject stem cells into the brain to see if it will regenerate. The trial is expected to take several months, with the researchers monitoring the brain for regeneration. The dead participants will be attached to a life support to "keep them alive," per Telegraph.
Clinical Trial on Brain Death: ReAnima Project
The trial is named the ReAnima project, which has been approved by the U.S. National Institutes of Health. The experts are confident that their undertaking will have some results within three months. "This represents the first trial of its kind and another step towards the eventual reversal of death in our lifetime," said Dr. Ira Pastor of Bioquark Inc.
Clinical Trial On Brain Death: Are Researchers Playing God?
Medical Daily reports that the researchers want to find out if it's possible to reboot the central nervous system after it has been declared brain dead. If the injected stem cells do grow and form a new brain, it could partly awaken the dead patient's consciousness.
The researchers are not planning to create Frankenstein with their study. "It is a long term vision of ours that a full recovery in such patients is a possibility, although that is not the focus," said Pastor. For now, the experts only want to find ways to improve treatments for patients who are in a state of coma and who have degenerative diseases like Alzheimer's and Parkinson's.
See Now: Top 30 Best The Incredibles 2 Toys